Carrie Martin Blanchard, PharmD, MPH


A Partnership to Optimize Medication Use and Patient Outcomes

Initiative promotes adoption of value-based care models in community pharmacy settings.

Jared Berberabe


Vaccine Additive Strengthens Immune Response, Offers Possibilities for Universal Flu Vaccine

By adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.

Harris Eyre, MD, PhD


Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important

Karen Dineen Wagner, MD, PhD


Latest on Pediatric Depression Treatments

Further evidence-based antidepressant treatments are needed for children and adolescents with depression.

Justina Petrullo


Wildfire Smoke Associated With Worse NSCLC Survival Rates After Surgical Resection

Wildfire smoke is a considerable contributor to air pollution, with wildfire smoke exposure consistently associated with respiratory morbidity including lung cancer risk.

Beth Mitchell, Senior Director of Government Affairs at AmerisourceBergen


How to Engage With Elected Officials When You Can't Meet Face to Face

Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.

Thelma King Thiel, RN, BA


Education is Key to Improving Hepatitis B Vaccination Rates

Resources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.

Logan Lutton


Widespread Support for Telemedicine Remains, Survey Shows

Research shows that telemedicine bridges gaps in healthcare access despite party affiliations.

Darby J.E. Lowe, MSc


College Students and Misuse of Substances

The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.

Aleksandra Bieniek, PharmD


First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA

Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.

Rana F. Hamdy, MD, MPH, MSCE


Health Care Workers Can be Part of the Climate Change Solution

Anesthetic gases and meter dose inhalers, how we use our antibiotics, how we use our resources for infection prevention and control, and how we use plastic and food in our hospitals all add up.

Peter Weinstein, DVM, MBA


Veterinary Prescriptions Made Easy

How can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?

Kimber Boothe, PharmD, MHA


Workforce Challenges for Health System Pharmacy

The COVID-19 pandemic has exposed the cracks in health system pharmacy. Here’s how the workforce can adapt.

Isabella Ciccone, MPH


FDA: Nerivio Cleared for Migraine Prevention

Nerivio received clearance in January 2021 for use in acute migraine.

Pooja Shah, PharmD, BCPPS


New Drug Approvals in Pediatrics

This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.

Danielle M. Alm, PharmD, BCPS, BCPPS


Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.

Giuliana Grossi


Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-Term

Black patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.

Kevin Ho, PharmD candidate


Abrocitinib for Atopic Dermatitis

The drug’s approval was based on the results of 3 clinical trials.

Quinn Everts


Don’t Get Caught Up With a HIPAA Violation

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

Natalie Catalan, PharmD candidate


Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.

Maxim Mikheev, PhD, MD, MSc


How Rare Cannabinoids Are Disrupting the Pharmaceutical Industry

By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.

Frank Diamond


FDA Issues EUA for First Oral Antiviral Pill for COVID-19

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.

© 2024 MJH Life Sciences

All rights reserved.